Cargando…

MRI and ultrasound versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in JIA. Do these imaging techniques have an additional value?

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Malattia, C, Consolaro, A, Pederzoli, S, Damasio, MB, Hasija, R, Mazzoni, M, Madeo, A, Beltramo, A, Viola, S, Buoncompagni, A, Mattiuz, C, Ravelli, A, Martini, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194406/ http://dx.doi.org/10.1186/1546-0096-9-S1-O12

Ejemplares similares

MRI and ultrasound versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in JIA. Do these imaging techniques have an additional value?
por: Malattia, C, et al.
Publicado: (2011)

2.4 Magnetic resonance imaging, ultrasonography and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis
por: Malattia, C, et al.
Publicado: (2008)

PReS-FINAL-2010: Predictive value of whole-body MRI in juvenile dermatomyositis
por: Malattia, C, et al.
Publicado: (2013)

Analysis of ceiling effect and score distribution of outcome measures in juvenile idiopathic arthritis (JIA)
por: Lattanzi, B, et al.
Publicado: (2008)

PReS-FINAL-2129: Whole-body versus localized magnetic resonance imaging in the assessment of juvenile dermatomyositis
por: Madeo, A, et al.
Publicado: (2013)

PW01-039 – Long-term efficacy of anakinra in SoJIA patients
por: Naselli, A, et al.
Publicado: (2013)

Quantitative assessment of synovitis in juvenile idiopathic arthritis using Dynamic Contrast-Enhanced Magnetic Resonance Imaging
por: Malattia, C, et al.
Publicado: (2008)

Children with juvenile idiopathic arthritis currently followed in a tertiary care setting have a better psychosocial well-being than healthy peers
por: Bertamino, M, et al.
Publicado: (2011)

Rapid and sustained effect of anti-TNF treatment in patients with ADA2 deficiency
por: Caorsi, R, et al.
Publicado: (2015)

Comparison of physician's, parent's and patient's global ratings made on linear or 21-circle visual analogue scales (VAS) in juvenile idiopathic arthritis (JIA)
por: Dalprà, S, et al.
Publicado: (2008)

Development and initial validation of a new functional ability tool for juvenile dermatomyositis
por: Varnier, GC, et al.
Publicado: (2011)

PReS-FINAL-2011: Preliminary validation of a new hybrid measure of muscle strength for juvenile dermatomyositis
por: Marafon, D, et al.
Publicado: (2013)

Evaluation of the power of six clustering features in identifying a homogeneous disease subset in juvenile idiopathic arthritis (JIA)
por: Magnani, A, et al.
Publicado: (2008)

Comparison of the accuracy of different definitions of clinical remission (CR) and minimal disease activity (MDA) in juvenile idiopathic arthritis (JIA)
por: Davì, S, et al.
Publicado: (2008)

Musculoskeletal ultrasound versus magnetic resonance in supporting clinical management of juvenile idiopathic arthritis
por: Lanni, Stefano, et al.
Publicado: (2014)

PReS-FINAL-2176: Declines in levels of disease activity and physical disability in children with juvenile idiopathic arthritis seen in standard clinical care over the last 25 years
por: Consolaro, A, et al.
Publicado: (2013)

PReS-FINAL-2193: Assessment of construct validity of new measures of global disease activity, physical function and quality of life in children with juvenile dermatomyositis
por: Ferrari, C, et al.
Publicado: (2013)

To evaluate the impact of a nurse-led JIA education program on parental satisfaction regarding knowledge of JIA and its management
por: Jones, J, et al.
Publicado: (2011)

Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data
por: De Benedetti, Fabrizio, et al.
Publicado: (2012)

The diagnostic role of hyperferritinemia in a tertiary care pediatric rheumatology setting
por: Sala, I, et al.
Publicado: (2008)

Development and initial validation of the parent acceptable symptom state in juvenile idiopathic arthritis (JIA)
por: Filocamo, G, et al.
Publicado: (2008)

Agreement between physicians and parents in rating functional ability of children with juvenile idiopathic arthritis
por: Palmisani, Elena, et al.
Publicado: (2007)

Etanercept efficacy in the treatment of chronic isolated inflammatory coxitis
por: Parodi, A, et al.
Publicado: (2008)

Predictors of response in patients with active systemic JIA (SJIA) receiving canakinumab: an exploratory analysis of pooled 12-week data
por: Ruperto, N, et al.
Publicado: (2014)

The effects of early aggressive therapy in JIA: results of the TREAT study
por: Wallace, Carol A, et al.
Publicado: (2012)

Potential value of cartilage and bone soluble biomarkers in evaluating joint damage in juvenile idiopathic arthritis
por: Pederzoli, Silvia, et al.
Publicado: (2014)

4.4 Different phenotype of anaemia in systemic juvenile idiopathic arthritis (s-JIA) compared to anaemia in other subtypes of JIA
por: Hinze, CH, et al.
Publicado: (2008)

Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis
por: Schiappapietra, B, et al.
Publicado: (2011)

Histone antibodies as a biomarker of uveitis in JIA
por: Nordal, Ellen B, et al.
Publicado: (2014)

Time of onset of iridocyclitis (IC) in children with juvenile idiopathic arthritis (JIA)
por: Verazza, S, et al.
Publicado: (2008)

14.4 Oligoarticular Juvenile Idiopathic Arthritis (JIA): can extension be predicted?
por: Hunter, PJ, et al.
Publicado: (2008)

A meta-analysis to estimate the “real” placebo effect in juvenile idiopathic arthritis (JIA) trials
por: Demirkaya, E, et al.
Publicado: (2011)

IL-18 production upon s100 stimulation is reduced in active sJIA patients compared to sJIA patients in remission and healthy controls
por: Haar, Nienke Ter, et al.
Publicado: (2014)

A multinational study of the epidemiology, treatment and outcome of childhood arthritis (epoca study): preliminary data from 6,940 patients
por: Consolaro, Alessandro, et al.
Publicado: (2014)

S100A12 as diagnostic tool in the differential diagnosis of sJIA associated MAS vs. hereditary or acquired HLH
por: Holzinger, D, et al.
Publicado: (2015)

PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH
por: De Benedetti, F, et al.
Publicado: (2013)

Final validation of a new composite disease activity score for juvenile idiopathic arthritis: the Juvenile Arthritis Disease Activity Score (JADAS)
por: Consolaro, A, et al.
Publicado: (2008)

PReS-FINAL-2177: Safety and lack of autoantibody production following influenza H1N1 vaccination in patients with juvenile idiopathic arthritis (JIA)
por: Aikawa, N, et al.
Publicado: (2013)

Serious infections in JIA patients upon MTX, TFN inhibitors and combinations
por: Horneff, Gerd, et al.
Publicado: (2014)

Safety and efficacy of varicella vaccination in children with JIA treated with biologic therapy
por: Toplak, Natasa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_93jb3dvs1eneoks3ujpk76qdou